This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Shedir Pharma Group Past Earnings Performance
Past criteria checks 2/6
Shedir Pharma Group has been growing earnings at an average annual rate of 13.4%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 6% per year. Shedir Pharma Group's return on equity is 16.2%, and it has net margins of 9.8%.
How Shedir Pharma Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BIT:SHE Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 24
61
6
6
0
31 Mar 24
60
6
6
0
31 Dec 23
59
6
6
0
30 Sep 23
59
6
6
0
30 Jun 23
58
6
5
0
31 Mar 23
56
6
5
0
31 Dec 22
53
6
5
0
30 Sep 22
51
5
5
0
30 Jun 22
49
4
5
0
31 Mar 22
47
4
5
0
31 Dec 21
45
4
4
0
30 Sep 21
44
4
4
0
30 Jun 21
43
3
4
0
31 Mar 21
43
4
4
0
31 Dec 20
43
4
4
0
30 Sep 20
44
3
5
0
30 Jun 20
45
3
5
0
31 Mar 20
47
3
5
0
31 Dec 19
51
3
5
0
30 Sep 19
50
4
5
0
30 Jun 19
49
5
5
0
31 Mar 19
49
6
5
0
31 Dec 18
47
7
5
0
31 Dec 17
40
3
4
0
Quality Earnings: SHE has high quality earnings.
Growing Profit Margin: SHE's current net profit margins (9.8%) are lower than last year (10.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SHE's earnings have grown by 13.4% per year over the past 5 years.
Accelerating Growth: SHE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SHE had negative earnings growth (-2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (9.5%).
Return on Equity
High ROE: SHE's Return on Equity (16.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/01/24 00:02
End of Day Share Price
2025/01/22 00:00
Earnings
2024/06/30
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shedir Pharma Group S.p.A. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.